Nanjing Well Pharmaceutical GroupLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Renrong Wu
Chief executive officer
CN¥899.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.1yrs |
| CEO ownership | 13.7% |
| Management average tenure | no data |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO
Renrong Wu (60 yo)
4.1yrs
Tenure
CN¥899,600
Compensation
Mr. Renrong Wu is Chairman, Director & CEO of Nanjing Well Pharmaceutical Group Co.,Ltd. from April 08, 2020. He joined the Nanjing Well Pharmaceutical Group Co.,Ltd.in February 2000.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 4.1yrs | CN¥899.60k | 13.68% CN¥ 449.5m | |
| Director | 4.1yrs | CN¥721.30k | 10.42% CN¥ 342.5m | |
| Director & VP | 4.1yrs | CN¥732.70k | 10.42% CN¥ 342.5m | |
| Chairman of the Supervisory Board | 4.1yrs | no data | 2.2% CN¥ 72.3m | |
| Director | 4.1yrs | no data | no data |
4.1yrs
Average Tenure
57yo
Average Age
Experienced Board: 603351's board of directors are considered experienced (4.1 years average tenure).